"Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors With Human Immunodeficiency Virus" currently #18 of 39 trials at clinicaltrialsdotcom. Posted 4/1/13.
I'm not sure which is the more bullish indication...the ongoing clinical mojo...
...or the Message Board lunacy that seems to accompany the clinical momentum.
At times it almost seems like a race.